Halozyme Therapeutics, Inc. (BMV:HALO)

Halozyme Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	61.86	115.85	118.37	234.2	118.72	147.7
Short-Term Investments	486.32	480.22	217.63	128.6	622.2	220.31
Cash & Short-Term Investments	548.18	596.07	336	362.79	740.92	368.01
Cash Growth	3.62%	77.40%	-7.38%	-51.03%	101.33%	-12.64%
Accounts Receivable	316.34	308.46	234.21	231.07	90.98	97.73
Inventory	181.51	141.86	127.6	100.12	53.91	60.75
Other Current Assets	76.65	38.95	48.61	45.02	40.48	28.27
Total Current Assets	1,123	1,085	746.42	739.01	926.29	554.76
Net Property, Plant & Equipment	71.52	75.04	74.94	75.57	8.79	10.59
Other Intangible Assets	366.31	401.83	472.88	546.65	-	-
Goodwill	416.82	416.82	416.82	409.05	-	-
Other Long-Term Assets	76.58	84.45	22.2	71.23	169.35	14.57
Total Assets	2,054	2,063	1,733	1,842	1,104	579.92
Accounts Payable	18.69	10.25	11.82	17.69	1.54	1.93
Accrued Expenses	115.59	128.85	100.68	99.76	24.44	20.48
Current Portion of Long-Term Debt	-	-	-	13.33	89.42	397.23
Unearned Revenue	-	-	-	-	1.75	1.75
Total Current Liabilities	134.28	139.1	112.49	130.79	117.15	421.39
Long-Term Debt	1,509	1,506	1,499	1,493	787.26	-
Other Long-Term Liabilities	77.77	54.76	37.72	48.16	3.07	7.49
Total Long-Term Liabilities	1,587	1,561	1,537	1,541	790.33	7.49
Total Liabilities	1,721	1,700	1,649	1,672	907.48	428.88
Common Stock	0.12	0.12	0.13	0.14	0.14	0.14
Additional Paid-in Capital	-	-	2.41	27.37	256.35	625.48
Accumulated Other Comprehensive Income	-28.4	3.83	-9.28	-0.92	-0.62	0.02
Retained Earnings	361.03	359.87	90.55	143.22	-58.91	-474.59
Shareholders' Equity	332.75	363.82	83.81	169.8	196.95	151.05
Total Liabilities & Equity	2,054	2,063	1,733	1,842	1,104	579.92
Total Debt	1,509	1,506	1,499	1,506	876.67	397.23
Net Cash (Debt)	-960.92	-909.72	-1,163	-1,143	-135.75	-29.22
Net Cash Per Share	-7.54	-7.03	-8.67	-8.13	-0.93	-0.21
Book Value	332.75	363.82	83.81	169.8	196.95	151.05
Book Value Per Share	2.61	2.81	0.62	1.21	1.34	1.07
Tangible Book Value	-450.38	-454.83	-805.89	-785.9	196.95	151.05
Tangible Book Value Per Share	-3.53	-3.51	-6.01	-5.59	1.34	1.07

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.